Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1992;1(4):273–279. doi: 10.1155/S0962935192000425

Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice

Robert G Caccese 1,✉, John L Zimmerman 1, Richard P Carlson 1
PMCID: PMC2365350  PMID: 18475473

Abstract

Collagen-induced arthritis (CIA) is an immunologically relevant animal model of human rheumatoid arthritis. Studies comparing the disease incidence in genetically susceptible male and female DBA/1LacJ mice demonstrated that under low density/low stress housing conditions, female mice had earlier onset (day 35) and higher disease incidence (25%) than the male mice (17% at day 49) when immunized with bovine type II collagen. A single subcutaneous or intraperitoneal injection of bacterial lipopolysaccharide (LPS) 17–24 days after collagen immunization greatly potentiated this standard CIA model in a dose related manner. 20–40 μg of LPS accelerated the onset of disease from day 35 to day 21 and exacerbated the clinical severity score from 0.27 to 2.00 at day 42. A similar administration of 6 μg of recombinant interleukin-β produced a comparable potentiated CIA model. The acute phase protein, serum amyloid P (SAP), was elevated in the serum at day 26 to 440 μg ml−1 for the LPS potentiated CIA mice compared to 65 μg ml−1 in the non-potentiated immunized CIA mice. There was a significant correlation (r = 0.78) between SAP levels and disease expression in the LPS treated CIA mice. The rapidity and uniformity of disease expression in this LPS potentiated CIA model will allow more and different drugs to be evaluated with a smaller number of animals.

Full Text

The Full Text of this article is available as a PDF (561.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bliven M. L., Wooley P. H., Pepys M. B., Otterness I. G. Murine type II collagen arthritis. Association of an acute-phase response with clinical course. Arthritis Rheum. 1986 Sep;29(9):1131–1138. doi: 10.1002/art.1780290911. [DOI] [PubMed] [Google Scholar]
  2. Courtenay J. S., Dallman M. J., Dayan A. D., Martin A., Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980 Feb 14;283(5748):666–668. doi: 10.1038/283666a0. [DOI] [PubMed] [Google Scholar]
  3. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  4. Griswold D. E., Hillegass L. M., Meunier P. C., DiMartino M. J., Hanna N. Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arthritis Rheum. 1988 Nov;31(11):1406–1412. doi: 10.1002/art.1780311110. [DOI] [PubMed] [Google Scholar]
  5. Griswold D. E., Hillegass L., Antell L., Shatzman A., Hanna N. Quantitative Western blot assay for measurement of the murine acute phase reactant, serum amyloid P component. J Immunol Methods. 1986 Jul 24;91(2):163–168. doi: 10.1016/0022-1759(86)90474-6. [DOI] [PubMed] [Google Scholar]
  6. Hom J. T., Bendele A. M., Carlson D. G. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J Immunol. 1988 Aug 1;141(3):834–841. [PubMed] [Google Scholar]
  7. Hom J. T., Gliszczynski V. L., Cole H. W., Bendele A. M. Interleukin 1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs. Agents Actions. 1991 Jul;33(3-4):300–309. doi: 10.1007/BF01986577. [DOI] [PubMed] [Google Scholar]
  8. Killar L. M., Dunn C. J. Interleukin-1 potentiates the development of collagen-induced arthritis in mice. Clin Sci (Lond) 1989 May;76(5):535–538. doi: 10.1042/cs0760535. [DOI] [PubMed] [Google Scholar]
  9. Le P. T., Mortensen R. F. In vitro induction of hepatocyte synthesis of the acute phase reactant mouse serum amyloid P-component by macrophages and IL 1. J Leukoc Biol. 1984 Jun;35(6):587–603. doi: 10.1002/jlb.35.6.587. [DOI] [PubMed] [Google Scholar]
  10. Le P. T., Muller M. T., Mortensen R. F. Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine. J Immunol. 1982 Aug;129(2):665–672. [PubMed] [Google Scholar]
  11. Mortensen R. F., Beisel K., Zeleznik N. J., Le P. T. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation. J Immunol. 1983 Feb;130(2):885–889. [PubMed] [Google Scholar]
  12. Mortensen R. F., Shapiro J., Lin B. F., Douches S., Neta R. Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins. J Immunol. 1988 Apr 1;140(7):2260–2266. [PubMed] [Google Scholar]
  13. Stuart J. M., Cremer M. A., Kang A. H., Townes A. S. Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum. 1979 Dec;22(12):1344–1351. doi: 10.1002/art.1780221205. [DOI] [PubMed] [Google Scholar]
  14. Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977 Sep 1;146(3):857–868. doi: 10.1084/jem.146.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wooley P. H., Chapedelaine J. M. Immunogenetics of collagen-induced arthritis. Crit Rev Immunol. 1987;8(1):1–22. [PubMed] [Google Scholar]
  16. Wooley P. H., Luthra H. S., Stuart J. M., David C. S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1;154(3):688–700. doi: 10.1084/jem.154.3.688. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES